Fresh insights into how immune cells are regulated could signal a new approach to tackling infections. Researchers have found that oxygen levels in the body can profoundly change the way immune cells behave. Scientists say the findings pave the way for new therapies that target the immune response to infection, with the potential to boost existing antibiotic treatments.
The research in mice found that bacterial infections have vastly different outcomes depending on levels of oxygen in the body when the infection takes hold.
If oxygen levels are low when infection strikes, the immune system launches a massive overreaction. A fatal illness ensues even though the bacteria have been cleared from the body. Exposure to low oxygen before infection, however, seems to protect the body from illness without compromising its ability to fight off bacteria. Researchers say the effects are caused by changes to the way the cells use energy, which reprograms their response.
If human cells are found to behave in the same way, tweaking their oxygen sensing mechanisms could hold the key to tackling infections, the team says. The findings are particularly relevant for people with chronic lung conditions, such as emphysema. They often have low levels of oxygen in their body and are more vulnerable to infections.
The study was carried out by scientists in the Medical Research Council Centre for Inflammation Research at the University of Edinburgh and is published in the journal Science Immunology.
Dr. Sarah Walmsley, of the MRC Centre for Inflammation Research at the University of Edinburgh, said, "We are excited by our observation that oxygen levels can regulate immune cell responses to infection. Targeting these pathways could have the potential to improve outcomes from infections where oxygen is limited."
Source: University of Edinburgh
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.